The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 337-345.e26 , August 2010

Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression

Received 1 August 2009 ,Revised 19 November 2009 ,Accepted 19 December 2009.

References 

  1. Ihnken K, Morita K, Buckberg GD, Matheis G, Sherman MP, Allen BS, et al. Studies of hypoxemic/reoxygenation injury: without aortic clamping. II. Evidence for reoxygenation damage. J Thorac Cardiovasc Surg. 1995;110:1171–1181
  2. Teoh KH, Mickle DA, Weisel RD, Li RK, Tumiati LC, Coles JG, et al. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg. 1992;104:159–164
  3. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol Heart Circ Physiol. 1991;261:H632–H638
  4. Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman MS. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation. 2001;103:1551–1556
  5. Modi P, Imura H, Caputo M, Pawade A, Parry A, Angelini GD, et al. Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg. 2002;124:1035–1036
  6. del Nido PJ, Mickle DA, Wilson GJ, Benson LN, Coles JG, Trusler GA, et al. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. Circulation. 1987;76(suppl):V174–V179
  7. Kaynak B, von Heydebreck A, Mebus S, Seelow D, Hennig S, Vogel J, et al. Genome-wide array analysis of normal and malformed human hearts. Circulation. 2003;107:2467–2474
  8. Konstantinov IE, Coles JG, Boscarino C, Takahashi M, Goncalves J, Ritter J, et al. Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions. J Thorac Cardiovasc Surg. 2004;127:746–754
  9. Arab S, Konstantinov IE, Boscarino C, Cukerman E, Mori A, Li J, et al. Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery. J Thorac Cardiovasc Surg. 2007;134:74–81e1-2
  10. Sharma HS, Peters TH, Moorhouse MJ, van der Spek PJ, Bogers AJ. DNA microarray analysis for human congenital heart disease. Cell Biochem Biophys. 2006;44:1–9
  11. Hindmarch C, Yao S, Beighton G, Paton J, Murphy D. A comprehensive description of the transcriptome of the hypothalamoneurohypophyseal system in euhydrated and dehydrated rats. Proc Natl Acad Sci U S A. 2006;103:1609–1614
  12. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3
  13. Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG, et al. Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem. 2003;278:19280–19285
  14. Bishopric NH, Andreka P, Slepak T, Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol. 2001;1:141–150
  15. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res. 2004;61:448–460
  16. Wang D, You Y, Lin PC, Xue L, Morris SW, Zeng H, et al. Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proc Natl Acad Sci U S A. 2007;104:145–150
  17. Joung YH, Lim EJ, Kim MS, Lim SD, Yoon SY, Lim YC, et al. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Int J Oncol. 2008;33:477–484
  18. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, Henson PM, et al. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J Biol Chem. 2002;277:11772–11779
  19. Kogel D, Prehn JH, Scheidtmann KH. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays. 2001;23:352–358
  20. Yang SH, Sharrocks AD, Whitmarsh AJ. Transcriptional regulation by the MAP kinase signaling cascades. Gene. 2003;320:3–21
  21. Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005;38:47–62
  22. Muhlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C, et al. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J Biol Chem. 1998;273:33091–33098
  23. Subramanian V, Krishnamurthy P, Singh K, Singh M. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice. Am J Physiol Heart Circ Physiol. 2007;292:H673–H683
  24. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, et al. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation. 1997;96:3063–3071
  25. Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, et al. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension. 1999;33:663–670

 This work was funded by the British Heart Foundation, the Garfield Weston Trust and the Bristol NIHR BRU in Cardiovascular Medicine. M. T. Ghorbel was supported by an Intermediate Research Fellowship from the British Heart Foundation.

 Disclosures: None.

PII: S0022-5223(10)00262-X

doi: 10.1016/j.jtcvs.2009.12.055

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 2 , Pages 337-345.e26 , August 2010

Article Tools

* Image Usage & Resolution